COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis
Sign Up to like & getrecommendations! Published in 2021 at "3 Biotech"
DOI: 10.1007/s13205-021-03080-4
Abstract: The post-coronavirus disease (COVID-19) mucormycosis is a deadly addition to the pandemic spectrum. Although it’s a rare, aggressive, and opportunistic disease, the associated morbidity and mortality are significant. The complex interplay of factors aggravating CAM… read more here.
Keywords: associated mucormycosis; early rapid; technologies early; mucormycosis ... See more keywords
Adapting to Evolving Technologies and Treatment Guidelines in a Procedural Trial
Sign Up to like & getrecommendations! Published in 2023 at "Neurology"
DOI: 10.1212/wnl.0000000000207075
Abstract: Multiple challenges confront procedural trials, including slow enrollment, lack of equipoise among patients and physicians, and failure to achieve adequate masking. Nonetheless, randomized clinical trials provide the best evidence of efficacy. The evolution of technology,… read more here.
Keywords: evolving technologies; technologies treatment; treatment guidelines; trial ... See more keywords